Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001495800-16-000014)

Filing Details

Accession Number:: 0001495800-16-000014
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-04-05 10:24:01
Reporting Period:: 2016-04-01

Filing Date:: 2016-04-05
Accepted Time:: 2016-04-05 10:24:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
899923	Myriad Genetics Inc	MYGN	In Vitro & In Vivo Diagnostic Substances (2835)	870494517

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1495800	A. Gary King	320 Wakara Way Salt Lake City UT 84108	Exec. Vp International Ops	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-04-01	15,000	$14.88	95,640	No	4	M	Direct
Common Stock	Disposition	2016-04-01	15,000	$38.12	80,640	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2016-04-01	15,000	$0.00	15,000	$14.88

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,120		2020-08-03	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan.
The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.